Daynna Wolff to Breast Neoplasms
This is a "connection" page, showing publications Daynna Wolff has written about Breast Neoplasms.
Connection Strength
0.311
-
HER2 testing: a review of detection methodologies and their clinical performance. Expert Rev Mol Diagn. 2007 Jan; 7(1):53-64.
Score: 0.143
-
Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases. Turk Patoloji Derg. 2016; 32(3):178-85.
Score: 0.067
-
Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers. Genes Chromosomes Cancer. 2006 Nov; 45(11):983-94.
Score: 0.035
-
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. Arch Pathol Lab Med. 2006 Mar; 130(3):325-31.
Score: 0.034
-
HER-2/neu amplified breast cancers in South Carolina. J S C Med Assoc. 2005 Apr; 101(4):97-9.
Score: 0.032